date,title,source
Oct-18-18,"Investor Expectations to Drive Momentum within Teradata, Liberty TripAdvisor, CPI Card Group, Cara Therapeutics, Ocular Therapeutix, and G-III Apparel Group, LTD  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-19-18,Ocular Therapeutix stock drops 10% after FDA warning letter,MarketWatch
Oct-22-18,"Ocular Therapeutix (OCUL): ReSure Warning Letter Insignificant to Pipeline, Says Analyst",SmarterAnalyst
Oct-30-18,Will Ocular Therapeutix (OCUL) Report Negative Earnings Next Week? What You Should Know,Zacks
Oct-31-18,Ocular Therapeutix To Report Third Quarter 2018 Financial Results,Business Wire
Nov-07-18,"Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-07-18,Ocular Therapeutix: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Ocular Therapeutix Reports Third Quarter 2018 Financial Results and Business Update,Business Wire
Nov-08-18,Edited Transcript of OCUL earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-12-18,"Recent Analysis Shows Clovis Oncology, Evertec, Etsy, Ring Energy, Ocular Therapeutix, and Destination Maternity Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-15-18,H.C. Wainwright Sees over 80% Upside Potential for These Three Biotech Stocks,SmarterAnalyst
Nov-21-18,Ocular Therapeutix to Present at the 30th Annual Piper Jaffray Healthcare Conference,Business Wire
Dec-04-18,Options Traders Expect Huge Moves in Ocular Therapeutix (OCUL) Stock,Zacks
Dec-06-18,"Ocular Therapeutix Announces the Hiring of Chad Brines, Vice President, Sales",Business Wire
Dec-20-18,"Are Insiders Buying Ocular Therapeutix, Inc. (NASDAQ:OCUL) Stock?",Simply Wall St.
Dec-20-18,Ocular Therapeutix Added to Nasdaq Biotechnology Index,Business Wire
Dec-26-18,Edited Transcript of OCUL earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Dec-28-18,Ocular Therapeutix Announces Completion of Debt Refinancing,Business Wire
Jan-07-19,"Purdue Pharma L.P. and Ocular Therapeutix, Inc. Announce Initiation of Collaborative Research Activities to Evaluate Innovative Formulations for Non-Opioid Treatments for Pain",Business Wire
Jan-11-19,Ocular (OCUL) Submits an sNDA for Eye Pain Drug Dextenza,Zacks
Jan-11-19,"The Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDA",Benzinga
Jan-22-19,"Detailed Research: Economic Perspectives on Inovalon, Merit Medical, Senseonics, Ocular Therapeutix, The Hartford Financial Services Group, and Synopsys  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Feb-06-19,"Is Ocular Therapeutix, Inc. (NASDAQ:OCUL) A Financially Sound Company?",Simply Wall St.
Feb-20-19,Ocular Therapeutix Announces Dosing of First Patient in OTX-TKI (tyrosine kinase inhibitor implant) Phase 1 Clinical Trial for the Treatment of Wet Age-related Macular Degeneration (AMD),Business Wire
Feb-21-19,Ocular Therapeutix Prices $37.5 Million Subordinated Convertible Debt Financing,Business Wire
Feb-22-19,Watch These Four Biotech Stocks Friday,ACCESSWIRE
Mar-01-19,Ocular Therapeutix To Report Fourth Quarter and Year End 2018 Financial Results,Business Wire
Mar-05-19,Ocular Therapeutix to Present at the Cowen and Company 39th Annual Health Care Conference,Business Wire
Mar-07-19,Ocular Therapeutix Inc (OCUL) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-07-19,Ocular Therapeutix Reports Fourth Quarter and Year End 2018 Financial Results and Business Update,Business Wire
Mar-11-19,Edited Transcript of OCUL earnings conference call or presentation 7-Mar-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-14-19,Edited Transcript of OCUL earnings conference call or presentation 7-Mar-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-21-19,Ocular Therapeutix to Host 2019 Research & Development Day,Business Wire
Mar-25-19,Ocular Therapeutix Reports Election of Leslie Williams to Board of Directors,Business Wire
Mar-26-19,Recro Pharma Falls as FDA Denies Approval to Pain Candidate,Zacks
Apr-03-19,Ocular Therapeutix to Present at the H.C. Wainwright Global Life Sciences Conference,Business Wire
Apr-23-19,Ocular Therapeutix Reports Changes to Board of Directors,Business Wire
Apr-24-19,Ocular Therapeutix to Present New Data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting and at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,Business Wire
Apr-30-19,"Ocular Therapeutix, Inc. Settles Litigation with Mati Therapeutics, Inc.",Business Wire
May-02-19,Ocular Therapeutix To Report First Quarter 2019 Financial Results,Business Wire
May-03-19,Analysts Estimate Ocular Therapeutix (OCUL) to Report a Decline in Earnings: What to Look Out for,Zacks
May-10-19,"Ocular Therapeutix (OCUL) Reports Q1 Loss, Tops Revenue Estimates",Zacks
May-10-19,Ocular Therapeutix: 1Q Earnings Snapshot,Associated Press
May-10-19,Ocular Therapeutix Reports First Quarter 2019 Financial Results and Business Update,Business Wire
May-17-19,Edited Transcript of OCUL earnings conference call or presentation 10-May-19 12:30pm GMT,Thomson Reuters StreetEvents
May-20-19,Ocular Therapeutix Announces Topline Results of Phase 3 Clinical Trial of OTX-TP for the Treatment of Glaucoma,Business Wire
May-21-19,Ocular's Glaucoma Drug Study Fails to Meet Primary Endpoint,Zacks
May-21-19,"Raymond James Downgrades Ocular Therapeutix, Remains Bullish On Pipeline",Benzinga
May-23-19,Edited Transcript of OCUL earnings conference call or presentation 10-May-19 12:30pm GMT,Thomson Reuters StreetEvents
May-30-19,Ocular Therapeutix to Present at Three Upcoming Investor Conferences,Business Wire
May-31-19,Options Traders Expect Huge Moves in Ocular (OCUL) Stock,Zacks
